title: Practice patterns of US neurologists in patients with SPMS and PPMS: A consensus study.
abstract: A modified Delphi process assessed current multiple sclerosis (MS) practice patterns for secondary and primary progressive MS (secondary progressive MS [SPMS] and primary progressive MS [PPMS]). In early 2011, 2 sequential, case-based surveys were administered to 75 US MS specialists to assess treatment practices and patient management. Respondents were from geographically diverse US academic (42%) and community (58%) treatment centers. There was consensus (≥75% agreement in responses) to switch disease-modifying therapies for a patient with SPMS with both MRI activity and disability progression (95%), but no consensus on treatment selection. For PPMS, responses supported diagnosis using spinal MRI (100%) and lumbar puncture (75%) and treatment initiation in patients with brain gadolinium-enhancing lesions with or without spinal cord lesions (85%); however, there was no consensus on treatment initiation with spinal cord lesions alone or initial therapy. The lack of agreement among US MS experts on the best treatment approaches for SPMS or PPMS highlights the need for effective therapies.
authors: Wayne State University School of Medicine (OK), Detroit, MI; Mount Sinai School of Medicine (AEM), New York, NY; Georgetown University Hospital (CT), Washington, DC; Baylor Institute for Immunology Research (JTP), Dallas, TX; and Infusion Communications (CJB), Haddam, CT.
authors: Omar
authors: O
authors: Khan
authors: Aaron E
authors: AE
authors: Miller
authors: Carlo
authors: C
authors: Tornatore
authors: J Theodore
authors: JT
authors: Phillips
authors: Christopher J
authors: CJ
authors: Barnes
references: Neurology. 2011 Jan 4;76(1 Suppl 1):S14-25
references: 21205678
references: Neurology. 2001 Dec 11;57(11):1969-75
references: 11739811
references: Mt Sinai J Med. 2011 Mar-Apr;78(2):192-206
references: 21425264
references: Neurology. 2010 Jun 15;74(24):2004-15
references: 20548045
references: Ann Neurol. 2011 Feb;69(2):292-302
references: 21387374
references: Neurology. 2002 Sep 10;59(5):679-87
references: 12221157
references: Clin Ther. 2010 Oct;32(11):1871-88
references: 21095482
references: Neurology. 2010 May 4;74(18):1463-70
references: 20439849
references: N Engl J Med. 2010 Feb 4;362(5):387-401
references: 20089952
references: Curr Neuropharmacol. 2010 Sep;8(3):305-15
references: 21358979
references: Neuron. 2006 Oct 5;52(1):61-76
references: 17015227
references: Mult Scler. 2010 Mar;16(3):342-50
references: 20106943
references: AJNR Am J Neuroradiol. 2010 Jun;31(6):983-9
references: 20019103
references: Neurology. 2008 Sep 2;71(10):766-73
references: 18765653
references: Arch Neurol. 2006 Dec;63(12):1686-91
references: 17172607
references: Lancet. 2002 Apr 6;359(9313):1221-31
references: 11955556
references: Lancet Neurol. 2007 Oct;6(10):903-12
references: 17884680
references: Drug Des Devel Ther. 2010 Nov 24;4:343-66
references: 21151622
references: Neurology. 2006 May 9;66(9):1384-9
references: 16682671